Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10862636rdf:typepubmed:Citationlld:pubmed
pubmed-article:10862636lifeskim:mentionsumls-concept:C0028128lld:lifeskim
pubmed-article:10862636lifeskim:mentionsumls-concept:C0005767lld:lifeskim
pubmed-article:10862636lifeskim:mentionsumls-concept:C0017661lld:lifeskim
pubmed-article:10862636lifeskim:mentionsumls-concept:C0003009lld:lifeskim
pubmed-article:10862636lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:10862636lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:10862636lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:10862636pubmed:issue7lld:pubmed
pubmed-article:10862636pubmed:dateCreated2000-9-12lld:pubmed
pubmed-article:10862636pubmed:abstractTextThe effects of renin-angiotensin system blockade on nitric oxide (NO), especially in pathological conditions, are far from being established. The influence of kinins and angiotensin type 2 receptor are largely speculative and based mainly on animal studies. This study was aimed to address these aspects in humans.lld:pubmed
pubmed-article:10862636pubmed:languageenglld:pubmed
pubmed-article:10862636pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10862636pubmed:citationSubsetIMlld:pubmed
pubmed-article:10862636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10862636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10862636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10862636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10862636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10862636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10862636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10862636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10862636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10862636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10862636pubmed:statusMEDLINElld:pubmed
pubmed-article:10862636pubmed:monthJullld:pubmed
pubmed-article:10862636pubmed:issn0931-0509lld:pubmed
pubmed-article:10862636pubmed:authorpubmed-author:RossiDDlld:pubmed
pubmed-article:10862636pubmed:authorpubmed-author:PiccoliGGlld:pubmed
pubmed-article:10862636pubmed:authorpubmed-author:ParadisiLLlld:pubmed
pubmed-article:10862636pubmed:authorpubmed-author:RoccatelloDDlld:pubmed
pubmed-article:10862636pubmed:authorpubmed-author:MengozziGGlld:pubmed
pubmed-article:10862636pubmed:authorpubmed-author:PolloniRRlld:pubmed
pubmed-article:10862636pubmed:authorpubmed-author:MossoRRlld:pubmed
pubmed-article:10862636pubmed:authorpubmed-author:TOPPD CDClld:pubmed
pubmed-article:10862636pubmed:authorpubmed-author:PicciottoGGlld:pubmed
pubmed-article:10862636pubmed:authorpubmed-author:CacaceGGlld:pubmed
pubmed-article:10862636pubmed:authorpubmed-author:BancaleEElld:pubmed
pubmed-article:10862636pubmed:authorpubmed-author:CesanoGGlld:pubmed
pubmed-article:10862636pubmed:authorpubmed-author:GigliolaGGlld:pubmed
pubmed-article:10862636pubmed:issnTypePrintlld:pubmed
pubmed-article:10862636pubmed:volume15lld:pubmed
pubmed-article:10862636pubmed:ownerNLMlld:pubmed
pubmed-article:10862636pubmed:authorsCompleteYlld:pubmed
pubmed-article:10862636pubmed:pagination988-93lld:pubmed
pubmed-article:10862636pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:meshHeadingpubmed-meshheading:10862636...lld:pubmed
pubmed-article:10862636pubmed:year2000lld:pubmed
pubmed-article:10862636pubmed:articleTitleEffects of angiotensin II blockade on nitric oxide blood levels in IgA nephropathy.lld:pubmed
pubmed-article:10862636pubmed:affiliationCentro di Immunopatologia (CMID), Ospedale L. Einaudi, Torino, Italy.lld:pubmed
pubmed-article:10862636pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10862636pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10862636pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:10862636pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed